Cargando…
Use of ChemoFx® for Identification of Effective Treatments in Epithelial Ovarian Cancer
Selection of appropriate chemotherapy, including identification of platinum resistance, is critical to effective management of advanced epithelial ovarian cancer (EOC). ChemoFx®, a multiple treatment marker (chemoresponse assay), has been developed to address this challenge and to improve outcomes i...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Public Library of Science
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4506277/ https://www.ncbi.nlm.nih.gov/pubmed/26213638 http://dx.doi.org/10.1371/currents.eogt.8b0b6fffc7b999b34bc4c8152edbf237 |